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Human Infections with Avian Influenza A (H7N9) Viruses
This health advisory provides an update on the avian influenza A (H7N9) virus [H7N9] situation and 
includes new recommendations on who should be tested for H7N9 in the United States. This document 
replaces guidance published on April 5, 2013, in CDC Health Advisory 344 “Human Infections with Novel 
Influenza A (H7N9) Viruses,” found at http://emergency.cdc.gov/HAN/han00344.asp. The updated 
guidance reflects the most current epidemiology of H7N9 cases, which indicates that almost all H7N9 
human infections have resulted in severe respiratory illness; H7N9 has been found rarely among those 
with milder disease. For that reason, CDC is changing its recommendations for H7N9 testing: The 
primary changes from previous guidance are (i) a new recommendation to test only patients with 
an appropriate exposure history and severe respiratory illness requiring hospitalization and (ii) a 
request that only confirmed and probable cases of human infection with H7N9 be reported to 
CDC. In the previous guidance issued on April 5, CDC recommended that all persons with relevant 
exposure history and illness compatible with influenza, regardless of severity be tested. CDC will continue 
to update these recommendations as more information becomes available. The current guidance is 
consistent with interim surveillance recommendations by the World Health Organization for H7N9 found at 
http://www.who.int/influenza/human animal interface/influenza h7n9/InterimSurveillanceRecH7N9 10M 
ay13.pdf
Summary and Background
As of June 3, 2013, Chinese public health officials have reported >130 cases of human infection with 
H7N9 from 10 provinces and municipalities in mainland China and Taiwan [1, 2]. Most patients were 
hospitalized with severe respiratory illness and reported poultry contact prior to illness onset [2, 3]. 
Preliminary results from influenza-like illness surveillance suggest that H7N9 has not caused widespread 
mild illness in China [4].
Although several clusters of human infection with H7N9 have been identified in China, sustained 
person-to-person transmission of the virus has not been demonstrated. At this time, no cases of 
human infection with H7N9 have been detected in the United States, despite testing of >60 persons 
with respiratory illness who reported recent travel to China.
Clinicians should consider the possibility of H7N9 infection in persons presenting with respiratory illness 
requiring hospitalization and an appropriate travel or exposure history. Influenza diagnostic testing in 
patients with severe respiratory illness for whom an etiology has not been confirmed may identify human 
cases of H7N9.
Confirmed and probable cases of human infection with H7N9 in the United States should be reported to 
CDC within 24 hours of initial detection. See http://www.cdc.gov/flu/avianflu/h7n9/case-definitions.htm. 
However, state health departments are encouraged to investigate all potential cases of H7N9 infection as 
described below in order to determine case status.
Interim Recommendations for Clinicians and State and Local Health Departments
CDC recommends the following testing practices based on the current epidemiology of H7N9 cases.
Case Investigation and Testing
• Patients who meet both the clinical and exposure criteria described below should be considered for 
H7N9 testing by reverse-transcription polymerase chain reaction (RT-PCR) methods. Decisions on 
diagnostic testing for influenza using RT-PCR should be made using available clinical and 
epidemiologic information, and additional persons in whom clinicians suspect H7N9 infection should 
also be tested.
Clinical Illness Criteria
i. Patients with new-onset severe acute respiratory infection requiring hospitalization (i.e., illness 
of suspected infectious etiology that is severe enough to require inpatient medical care in the 
judgment of the treating clinician).
AND
ii. Patients for whom no alternative infectious etiology is identified.
Exposure Criteria
i. Patients with recent travel (within 10 days of illness onset) to areas where human cases of H7N9
have become infected or to areas where avian influenza A (H7N9) viruses are known to be 
circulating in animals 1.
OR
ii. Patients who have had recent close contact (within 10 days of illness onset) with confirmed cases
of human infection with H7N92. Close contact may be regarded as coming within about 6 feet (2
meters) of a confirmed case while the case was ill (beginning 1 day prior to illness onset and 
continuing until resolution of illness). Close contact includes healthcare personnel providing care 
for a confirmed case, family members of a confirmed case, persons who lived with or stayed 
overnight with a confirmed case, and others who have had similar close physical contact.
• If infection with H7N9 is suspected based on current clinical and epidemiological screening criteria 
recommended by public health authorities, respiratory specimens should be collected with 
appropriate infection control precautions for novel virulent influenza viruses and sent to the state or 
local health department for testing. Clinicians should obtain a respiratory specimen from these 
patients, place the swab or aspirate in viral transport medium, and contact their state or local health 
department to arrange transport and request a timely diagnosis at a state public health laboratory or 
CDC. Viral culture should not be attempted in these cases. For additional guidance on diagnostic 
testing of patients under investigation for H7N9 infection, please see 
http://www.cdc.gov/flu/avianflu/h7n9/specimen-collection.htm.
• Commercially available rapid influenza diagnostic tests (RIDTs) may not detect H7N9 viruses in 
respiratory specimens. Therefore, a negative rapid influenza diagnostic test result does not exclude 
infection with H7N9. In addition, a positive test result for influenza A cannot confirm avian influenza 
virus infection because these tests cannot distinguish between influenza A virus subtypes (they do 
not differentiate between human influenza A viruses and novel3 influenza viruses). Therefore, when 
RIDTs are positive for influenza A and there is concern for novel influenza A virus infection, 
respiratory specimens should be collected and sent for RT-PCR testing at a state public health 
laboratory. Clinical treatment decisions should not be made on the basis of a negative rapid influenza 
diagnostic test result since the test has only moderate sensitivity 
(http://www.cdc.gov/flu/professionals/diagnosis/clinician guidance ridt.htm).
Infection Control
Clinicians should be aware of appropriate infection control guidelines for patients under investigation for
infection with novel influenza A viruses. For guidance on infection control precautions for H7N9 see
http://www.cdc.gov/flu/avianflu/h7n9-infection-control.htm.
Treatment
For guidance on treatment of patients under investigation for H7N9 with antiviral medications, or for
guidance on antiviral chemoprophylaxis of exposed contacts, see http://www.cdc.gov/flu/avianflu/h7n9-
antiviral-treatment.htm.
For More Information
• CDC avian influenza A (H7N9) virus information is available at http://www.cdc.gov/flu/avianflu/h7n9- 
virus.htm.
• WHO Situation Updates on avian influenza are available at 
http://www.who.int/influenza/human animal interface/avian influenza/archive/en/index.html.
• WHO “Frequently Asked Questions on human infection with A (H7N9) virus, China” is available at 
http://www.who.int/influenza/human animal interface/faq H7N9/en/index.html.
• The Chinese Center for Disease Control and Prevention (China CDC) “Questions and Answers about 
human infection with A (H7N9) avian influenza virus" is available at 
http://www.chinacdc.cn/en/research 5311/FAQ/201304/t20130418 80053.html.
• CDC general information about avian influenza viruses and how they spread is available at 
http://www.cdc.gov/flu/avianflu/avian-in-humans.htm.
End Notes:
As of June 3, 2013, China was the only country where H7N9 viruses were known to be circulating in 
animals or where human cases have become infected. Patients with direct or close contact with wild birds 
or poultry, or animal settings, such as live poultry markets while traveling in these areas should be 
strongly considered for H7N9 testing. For more information on countries affected, please see the CDC 
avian influenza A (H7N9) information page at http://www.cdc.gov/flu/avianflu/h7n9-virus.htm.
Contact investigation protocols for confirmed cases may supersede the recommendations described 
here; testing of close contacts with any level of respiratory illness may be pursued, if in the judgment of 
the investigators, this is warranted.
Influenza viruses that do not typically infect humans are called "novel" influenza viruses; this includes 
influenza viruses that typically infect birds and swine.
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